How should leptospirosis be treated in adults, including antibiotic regimens for mild to moderate disease versus severe disease and appropriate supportive care?

Leptospirosis Treatment in Adults

For mild to moderate leptospirosis, treat with oral doxycycline, penicillin, or cephalosporins; for severe disease (Weil's disease with jaundice, hepatorenal failure, or hemorrhage), use intravenous penicillin or ceftriaxone, though evidence shows antibiotics may not significantly alter outcomes in established severe disease, which is likely immunologically mediated.

Treatment Approach by Disease Severity

Mild to Moderate Disease (Early Bacteremic Phase)

Initiate treatment upon clinical suspicion given the non-specific nature of initial investigations 1. The bacteremic phase typically lasts 4-7 days with flu-like symptoms, myalgia (especially calves), and possibly conjunctival suffusion 1.

Antibiotic options for outpatient/mild disease:

• Penicillin (oral formulation)
• Doxycycline
• Amoxicillin
• Azithromycin (alternative)

Duration: 7 days for penicillin, doxycycline, and cephalosporins 2

The 2024 systematic review found that cefotaxime, azithromycin, doxycycline, ceftriaxone, and penicillin all significantly shortened defervescence time compared to control 3. However, a 2024 Cochrane review noted very low-certainty evidence for mortality benefit 2.

Severe Disease (Weil's Disease)

Clinical indicators requiring hospitalization and IV therapy:

• Jaundice
• Hepatorenal syndrome (elevated bilirubin with mild transaminase elevation, renal failure)
• Hemorrhage (due to capillary fragility, not coagulopathy)
• Thrombocytopenia
• Significant systemic toxicity

IV antibiotic regimens:

• Ceftriaxone or cefotaxime (preferred based on efficacy data 3)
• Penicillin G (alternative)

Duration: 7 days 2

Critical Caveat About Severe Disease

The evidence reveals a sobering reality: A systematic review cited in the UK guidelines found no benefit for antibiotic treatment in established leptospirosis based on three trials 1. The 2021 meta-analysis confirmed penicillin showed no effect on mortality versus placebo (OR 1.65; 95% CI 0.76-3.57) 4. The 2024 Cochrane review reinforced this with very low-certainty evidence 2.

Why this matters clinically: Severe disease is probably immunologically mediated rather than directly bacterial 1. Patients with classical Weil's disease can become very unwell despite therapy 1. However, most infectious disease specialists continue recommending antibiotics pending further evidence 1, and the 2024 network meta-analysis supports antibiotics for reducing defervescence time 3.

Supportive Care Requirements

For Severe Disease with Organ Dysfunction:

Renal support:

• Monitor for oliguria/anuria
• Dialysis may be required for acute kidney injury
• Urinalysis typically shows proteinuria and hematuria 1

Hepatic monitoring:

• High bilirubin with mild transaminase elevation is characteristic
• Distinguish from other causes of hepatorenal syndrome

Hematologic management:

• Monitor for thrombocytopenia and anemia
• Bleeding is due to capillary fragility, not coagulopathy—clotting tests often normal 1
• Transfusion support as needed

Fluid resuscitation:

• If signs of shock or severe sepsis develop, follow sepsis guidelines with initial 500 mL crystalloid bolus 5

Diagnostic Considerations Affecting Treatment Timing

Start antibiotics immediately upon suspicion before confirmatory testing 1. Serological confirmation takes 6-10 days after symptom onset (IgM titre >1:320 suggestive; 1:80-1:160 consistent with early infection) 1.

Blood cultures should be taken within first 5 days before antibiotics and kept at room temperature 1. However, do not delay treatment waiting for culture results.

Key Clinical Pitfalls

1. Don't wait for jaundice to treat: Early mild disease may be self-limiting, but treatment during the bacteremic phase is most effective 1

2. Recognize the biphasic pattern: Initial flu-like phase (4-7 days) followed 1-3 days later by immune phase with potential severe manifestations 1

3. Don't expect dramatic improvement with antibiotics in severe disease: The immune phase driving severe manifestations may not respond to antimicrobials 1, 4, 2

4. Look for epidemiologic clues: Fresh-water exposure (swimming, canoeing), occupational animal contact, flooding, or travel to endemic areas during rainy season 1, 6

5. Consider conjunctival suffusion as a diagnostic clue: This finding is suggestive of leptospirosis 1